9
total announcements
524412.BO · 15 min delayed
Aarey Drugs & Pharmaceuticals Ltd
Aarey Drugs & Pharmaceuticals Ltd has announced the closure of its trading window for insiders, designated persons, and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ended September 30, 2026.
Aarey Drugs & Pharmaceuticals Ltd
Aarey Drugs & Pharmaceuticals Ltd has announced the Notice and Integrated Annual Report for its 36th Annual General Meeting, scheduled to be held on September 30, 2026. The report includes audited financial statements for the year ended March 31, 2026, and resolutions for the appointment of a director and approval of related party transactions.
Aarey Drugs & Pharmaceuticals Ltd
Aarey Drugs & Pharmaceuticals Ltd has announced the notice of its 36th Annual General Meeting (AGM) for the FY 2025-26, to be held on September 30, 2026, through video conferencing. The AGM will consider the audited financial statements for the year ended March 31, 2026, and the appointment of a director in place of Mrs. Bina Ghatalia, who retires by rotation.
Aarey Drugs & Pharmaceuticals Ltd
Aarey Drugs & Pharmaceuticals Ltd has announced a book closure from September 24 to September 30, 2026, for its 36th Annual General Meeting.
Aarey Drugs & Pharmaceuticals Ltd
Aarey Drugs & Pharmaceuticals Ltd has published an extract of unaudited standalone financial results for the quarter and three months ended June 30, 2026, which have been considered, approved, and taken on record by the Board of Directors. The financial results have been published in 'News Hub' (English Newspaper) edition dated 15/08/2026 & in 'News Hub' (Marathi newspaper) edition dated 15/08/2026. The company has also uploaded the newspaper advertisement on its website.
Aarey Drugs & Pharmaceuticals Ltd
Aarey Drugs & Pharmaceuticals Ltd has announced its unaudited financial results for the quarter ended 30th June, 2026, along with a limited review report and MD/CFO certification. The company's trading window will be open after 48 hours.
Aarey Drugs & Pharmaceuticals Ltd
Aarey Drugs & Pharmaceuticals Ltd has announced its unaudited financial results for the first quarter ended June 30, 2026, with the board of directors approving the results and the audit committee recommending them. The company has also attached a statement of deviation or variation in the utilization of funds raised through convertible warrants.
Aarey Drugs & Pharmaceuticals Ltd
Aarey Drugs & Pharmaceuticals Ltd has scheduled a board meeting on 14th August 2026 to consider and approve the unaudited financial results for the quarter ended 30th June 2026.
Aarey Drugs & Pharmaceuticals Ltd
Aarey Drugs & Pharmaceuticals Ltd has allotted 2,520,000 equity shares to promoters and non-promoters at Rs. 47.85 per warrant, following the conversion of 2,520,000 warrants. The company's issued and paid-up capital has increased to Rs. 33,354,303.